BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 3035-3044
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3035
Table 7 Comparison of major adverse cardiac events between the two groups, n (%)
MACE event
Control group (n = 51)
Case management unit (n = 52)
χ2/t
P value
Myocardial infarction1 (1.96)0 (0.00)
Heart failure1 (1.96)1 (1.92)
Malignant arrhythmia2 (3.92)1 (1.92)
Cardiac readmission5 (9.80)2 (3.85)
Cerebral apoplexy1 (1.96)0 (0.00)
reCABG1 (1.96)0 (0.00)
Cumulative MACE incidence11 (21.57)4 (7.69)3.9850.046


Write to the Help Desk